Episodi

  • TWiV 1165: What doesn't kill us primes our macrophages

    TWiV 1165: What doesn't kill us primes our macrophages

    · This Week in Virology

    TWiV notes the passing of virologist Diane Griffin, first H5N1 influenza virus in US pigs, Innate immune control of influenza virus interspecies adaptation via IFITM3, and antiviral trained innate immunity in alveolar macrophages after SARS-CoV-2 infection reduces secondary influenza A virus disease.

    Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server MicrobeTV Fundraiser Diane Griffin passes (Johns Hopkins) Diane Griffin on TWiV 453 First H5N1 influenza virus in US pigs (CIDRAP) IFITM3 controls interspecies influenza virus infection (Nat Comm) Trained innate immunity by alveolar macrophages (Immunity) Timestamps by Jolene. Thanks! Weekly Picks

    Angela – See a giant ‘ghost particle’ detector and more — October’s best science images
    Brianne – October 27 APoD: Bat nebula
    Dickson – Nikon Small World Contest 2024 winners
    Kathy – AAAS 150th anniversary video, celebrating scientists and Pew’s 2024 annual Trust in Science survey findings
    Rich – Cats Basically Are a Liquid After All, Study Confirms
    Alan – HHMI’s Beautiful Biology site
    Vincent – EcoHealth Alliance Fights Back

    Listener Picks

    Hunter – Don’t stop me now: Queen’s Brian May on saving badgers — and the scientific method
    Anne – Reasons to be cheerful

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1164: Clinical update with Dr. Daniel Griffin

    TWiV 1164: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin informs us about the World Health Organization research and development plan to combat endemic pathogens including hepatitis C virus, RSV and dengue virus, another case of mpox in Britian, the Marburg virus outbreak in Rwanda, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, if there is a benefit to additional COVID vaccinations after the initial series, ISDA guideline for using anti-SARS-CoV-2 monoclonal antibody therapy for prophylaxis, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, if and how do severe secondary bacterial infections develop following SARS-CoV-2 infection, and if COVID-19 associates with a risk of autoimmune and autoinflammatory connective tissue disorders.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Is the WHO the world’s NIH: endemic pathogens initiative (eBioMedicine) Another two cases of mpox in Britian (Reuters) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg Virus fact sheet (Rwanda Biomedical Centre) Influenza weekly surveillance report: cliff notes (CDC FluView) RSV NETwork (CDC RSV) Respiratory virus activity (CDC Respiratory Illnesses) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Symptom reduction after additional vaccine dose during Omicron (OFID) IDSA Guideline update for SARS-CoV-2 monoclonal antibody pemivibart pre-exposure prophylaxis (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center near you
.if in NY (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Secondary bacterial infection follows COVID-19 (Nature Communications) Daniel Griffin’s evidence-based medical practices for long COVID (OFID) Autoimmune and autoinflammatory connective tissue disorders following COVID-19 (JAMA Dermatology) Letters read on TWiV 1164 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • Episodi mancanti?

    Fai clic qui per aggiornare il feed.

  • TWiV 1163: Hepadnaviridae in the heartland

    TWiV 1163: Hepadnaviridae in the heartland

    · This Week in Virology

    From the 2024 International Hepatitis B virus meeting in Chicago, TWiV speaks with Mala Maini and John Tavis about their careers, the replication and transmission of HBV, and the HBV Foundation.

    Hosts: Vincent Racaniello and Rich Condit

    Guests: Mala Maini and John Tavis

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Immunobiology and pathogenesis of hepatitis B virus infection (Nat Rev Immunol) HBV Foundationhttps://www.hepb.org/ Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1162: Clinical update with Dr. Daniel Griffin

    TWiV 1162: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin informs us about “walking pneumonia”, the phase of the polio supplemental immunization campaign in Gaza, mpox circulation, the Marburg virus outbreak in Rwanda, the beginning of influenza season, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, contrasting public health concerns between the US and the UK, if mRNA boosters affect mucosal immunity against SARS-CoV-2 infection, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, if antiviral therapy prevents long COVID and viral sequalae in healthy young marines.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Mycoplasma pneumoniae infections increasing (CDC) Polio vaccination campaign restarts (Reuters) North Gaza polio campaign postponed (Reuters) 1St clade 1b mpox in UK (GOV.UK) UK imports mpox (CIDRAP) Clinical trial of MVA-BN for children (Bavarian-Nordic) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg Virus fact sheet (Rwanda Biomedical Centre) Laboratory confirmed influenza associated hospitalizations 2010-2023 (CDC) Influenza weekly surveillance report: cliff notes (CDC FluView) Mucosal nirsevimab levels in breakthrough bronchiolitis (LANCET Infectious Diseases) RSV NETwork (CDC RSV) Respiratory virus activity (CDC Respiratory Illnesses) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) UK public health data tracker (UKHSA) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Repeat COVID-19 mRNA vaccination contributes to mucosa immunity (Science Translational Medicine) XBB.1.5 mRNA booster vaccination limited mucosal immunity (Science Translational Medicine) I repeat: COVID mRNA booster vaccinations suboptimal respiratory mucosal immunity (Science Translational Medicie) Facial Palsy after COVID-19 vaccination? (Emerging Infectious Diseases) New preventive COVID-19 agent (ISDA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center near you
.if in NY (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Viral and symptom rebound following monoclonal antibody therapy (JID) Drug interaction checker (University of Liverpool) Nirmatrelvir plus ritonavir reduces COVID-19 hospitalization and prevents long COVID (Scientific Reports) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo (JAMA Network Open) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Clinical and functional assessment of SARS-CoV-2 sequelae among young marines (LANCET: Regional Health Americas) Letters read on TWiV 1162 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1161: Baby you can drive my gene

    TWiV 1161: Baby you can drive my gene

    · This Week in Virology

    TWiV reviews continuing expansion of poliovirus type 2, removal of influenza B/Yamagata from the vaccine, Nobel Prize for miRNAs, protective immune response with a adenovirus-associated virus vector expressing a computationally designed hemagglutinin, and viral gene drive during herpes simplex 1 infection in mice.

    Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Continued expansion of type 2 poliovirus (reliefweb) No more polio case map at polioeradication.org B/Yamagata removed from flu vaccine (NPR) Nobel Prizes for miRNA (ScienceInsider) AAV-vectored influenza vaccine (J Virol) Herpesvirus type 1 gene drive in mice (Nat Commun) Timestamps by Jolene. Thanks! Weekly Picks

    Brianne – Virus and Vaccines Information Page from NIH All of Us Research Program
    Kathy – For a Pivotal Vaccine: Trial, Error and Two Young Lives
    Rich – October 17 2024 APOD: The Clipper and the Comet
    Alan – Opening a deep-sea vent with a crowbar
    Vincent – The expanding world of neuroscience

    Listener Pick

    Jason – Solar eclipse on Mars and Polaris Program and their Harmony of Resilience
    Ryan – New York’s childhood vaccine coverage remains high

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1160: Clinical update with Dr. Daniel Griffin

    TWiV 1160: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin informs us about mpox circulation, the Marburg virus outbreak in Rwanda, new recommendations for the RSV and pneumococcal vaccines by the CDC, the beginning of influenza season, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, contrasting public health concerns between the US and the UK, what the risk of SARS-CoV-2 transmission is when indoors, the difference between NVX-CoV2327 and BNT162b2 for adolescents, why 65 years and older should get a second boost of the COVID-19 vaccine, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, the clinical trial for evaluating how novel treatments of COVID-19 affect long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome after SARS-CoV-2 infection.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Grim marker: mpox over a 1000 deaths in Africa (CIDRAP) Global trend of mpox outbreak 2022-2024 (WHO) Second time mpox is a global public health emergency (Reuters) Mpox variant in Germany (Reuters) Epidemiological analysis of confirmed mpox cases in Burundi (EuroSurveillance) The 63rd case of Marburg virus infections in Rwanda (CIDRAP) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg virus fact sheet (Rwanda Biomedical Centre) FDA approves RSV vaccine ABRYSVO for 18-59 individuals of increased risk (Pfizer) Respiratory syncytial virus infection-NET (CDC) New pneumococcal vaccine recommendations
..it’s a virus? (CDC Newsroom) Recommending PREVNAR 20, 20 valent pneumococcal conjugate vaccine for 50 and over (Pfizer) And one more, CAPVEXIVE, pneumococcal 21 valent conjugate vaccine (Merck) Penumococcoal 21-valent conjugate vaccine CAPVEXIVE(MerckVaccines.com) Influenza surveillance: Key updates (CDC) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) What is happening across the pond? (UKHSA data dashboard) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Risk of SARS-CoV-2 transmission when indoors (JID) NVX-CoV2327 vs BNT162b2 vaccines in adolescents (Pediatric Infectious Disease Journal) Second dose of 2024-2025 COVID19 vaccine recommended for 65 and older (CDC Newsroom) New preventive COVID-19 agent (ISDA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Viral and symptom rebound following monoclonal antibody therapy (JID) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary, Dr. Daniel Griffin (Blood Advances) Novel treatments for acute COVID-19 should account for long COVID (JID) The persistence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) after SARS-CoV-2 infection (Journal of Infection) Letters read on TWiV 1160 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1159: Eliminating cervical cancer, and endometrial immunity

    TWiV 1159: Eliminating cervical cancer, and endometrial immunity

    · This Week in Virology

    Vincent travels to the Karolinska Institute in Stockholm to meet up with Niklas Björkström and Joakim Dillner to review their research on the endometrial immune system, and the plan to eliminate cervical cancer in Sweden.

    Host: Vincent Racaniello

    Guests: Niklas Björkström and Joakim Dillner

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Endometrial immune system variation (Sci Immunol) Immune defense in the womb (News from Karolinska) HPV vaccination and screening for elimination (Nat Comm) Cervical cancer elimination strategies (Int J Cancer) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1158: Clinical update with Dr. Daniel Griffin

    TWiV 1158: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin informs us about mpox circulation and new vaccine approval, the Marburg virus outbreak in Rwanda, and the largest outbreak of whooping cough in a decade before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, immunity among those over 65th following the 3rd dose of the COVID-19 mRNA vaccine, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, how well the SARS-CoV-2 rapid antigen test performed, what do when healthcare workers succumb to SARS-CoV-2 infection, the effect of remdesivir on survival and readmission of hospitalized patients, if cognitive impairment following virus infection impairs one’s driving and how long COVID affects Chinese society.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Undiagnosed MPXV infections are high in men who have sex with men (BMC Infectious Diseases) WHO, now a vaccine approval agency, Jynneos for teens (CIDRAP) Mpox outbreak global trends (WHO) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg virus fact sheet (Rwanda Biomedical Centre) Largest whooping cough outbreak in US in a decade (NPR) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Insurance relates to effectiveness and waning of immunity following 3rd dose of mRNA COVID-19 vaccine? (JID) New preventive COVID-19 agent (ISDA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) How well do you test: performance of the SARS-CoV-2 antigen rapid detection test (eBioMedicine) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Remdesivir-associated survival outcomes among immunocompromised patients (CID) Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission in Vulnerable Patients (CID) Measurement of circulating viral antigens post-SARS-CoV-2 infection (CMI: Clinical Microbiology and Infection) DUCI: driving under cognitive influence of COVID-19 (Neurology) Long COVID facts and findings: (LANCET: Regional Health Western Pacific) Letters read on TWiV 1158 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1157: Superworm liquefaction and a pandemic prophylactic

    TWiV 1157: Superworm liquefaction and a pandemic prophylactic

    · This Week in Virology

    TWiV reviews Marburg virus outbreak in Rwanda, cryo-EM based discovery of a parvovirus causing black wasting disease in farmed beetles, and a mosaic nanoparticle experimental vaccine that elicits cross-reactive sarbecovirus responses in pre-vaccinated animals.

    Hosts: Vincent Racaniello, Alan Dove, and Brianne Barker

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Marburg virus disease, Rwanda (WHO) Suspected German Marburg case tests negative (Politico) Cryo-EM discovery of insect parvovirus (Cell) Mosaic sarbecovirus nanoparticle experimental vaccine (Cell) Letters read on TWiV 1157 Timestamps by Jolene. Thanks! Weekly Picks

    Brianne – ASM Lesson Plans
    Alan – A City on Mars, and this blog by a ham radio operator hit by Hurricane Helene
    Vincent – How to Win A Nobel Prize

    Listener Pick

    Laura – Science of Public Communication (original article)

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1156: Clinical update with Dr. Daniel Griffin

    TWiV 1156: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin updates us about polio SIA campaign in Gaza, the durability of protection following administration of GSK’s recombinant antigen RSV vaccine, mpox in an Ugandan jail, the Marburg virus outbreak in Rwanda, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, immunogenicity, reactogenicity and safety of different COVID-19 vaccine platforms, disease severity in those not previously vaccinated with those vaccinated but not infected, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if COVID-19 doubles the risk for heart attacks, stroke and death and if COVID-19 affects the regions of the brainstem.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Polio: second round of vaccination in Gaza (Reuters) Season 3 for GSK RSV vaccine protection (CIDRAP) Positive data for Arexvy, the respiratory syncytial virus vaccine (GSK) Mpox convicted felon: in Ugandan prison (Reuters) How to stop Marburg virus (Rwanda Biomedical Centre) Marburg virus fact sheet (Rwanda Biomedical Centre) CDC summary of the “Rwanda Marburg Situation” (CDC) 700 doses of a Marburg vaccine from the Sabin Vaccine Institute to Rwanda (CIDRAP) USAID mobilizes Marburg outbreak response in Rwanda (United States Agency International Development) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) PICOBOO: immunogenicity, reactogenicity and safety of different COVID-19 vaccine (Journal of Infection) COVID-19 in previously unvaccinated compared with previously uninfected vaccinated (JID) New preventive COVID-19 agent (ISDA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) COVID Data tracker (CDC Differences in COVID-19 outpatient antiviral treatment (MMWR) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) COVID-19 is a coronary artery disease with genetic interaction with ABO blood type (AHAIASA Journals) COVID-19 doubles risk of heart attack, stroke and death (EurekaAlert!) QTL mapping at 7T in COVID-19: brainstem and outcomes (Brain) Letters read on TWiV 1156 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1155: Spillover in stall A

    TWiV 1155: Spillover in stall A

    · This Week in Virology

    TWiV reviews mask effectiveness against respiratory infections, EEE death in NY State, viruses with zoonotic potential in farmed fur animals, and genetic tracing of market wild life and viruses at the Huanan Seafood Market, the epicenter of the COVID-19 pandemic.

    Hosts: Vincent Racaniello, Alan Dove, and Rich Condit

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Review confirms mask effectiveness (original article) EEE death in Ulster County NY (CBS News) EEE on TWiV 1145 Viruses of farmed fur animals (Nature) Tracing of wildlife and viruses at COVID-19 epicenter (Cell) Letters read on TWiV 1155 Timestamps by Jolene. Thanks! Weekly Picks

    Rich – Immunize.org, Vaccineinformation.org, National Network of Immunization Coalitions
    Alan – Birdcast
    Vincent – A universal framework for inclusive 15-minute cities

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1154: Clinical update with Dr. Daniel Griffin

    TWiV 1154: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin discusses the Marburg virus outbreak in Rwanda, the lack of immune durability following pertussis vaccination, recommendations for maternal vaccination and antibody therapy to protect against infant RSV, vaccine security for Mpox, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, how to put on and take off PPE to avoid contamination, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, the lack of immune durability elicited by mRNA vaccine and the finding of how SARS-CoV-2 infection impacts memory, cognition and reduces grey matter volume.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Rwanda: Marburg virus disease (WHO) Passport required?
..Marburg virus commutes to Germany (CIDRAP) Outbreak of whooping cough/pertussis
..no lifelong immunity following vaccination? (Bloomberg Protection of infants by maternal antibodies against RSV by either vaccination or nirsevimab (MMWR) WHO recommendations for RSV: maternal vaccination and antibody shot (Reuters) Ziresovir for RSV hospitalized infants (NEJM) Crawling to effective anti-RSV countermeasures (NEJM) The $800 million pledge for African mpox response (Reuters) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Doffing your PPE– contact precautions (CID) mRNA vaccination does not elicit durable immune response (Nature Medicine) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Mechanisms of long COVID and therapeutics (Cell) Post hospitalization cognitive deficits and grey matter reduction 1 year after COVID-19 (Nature Medicine) Letters read on TWiV 1154 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1153: Viruses that (can) make you well

    TWiV 1153: Viruses that (can) make you well

    · This Week in Virology

    From the Viruses of Microbes meeting in Cairns, Australia, TWiV speaks with Krystyna and Rob about their research on using bacteriophages to treat bacterial infections.

    Hosts: Vincent Racaniello and Jolene Ramsey

    Guests: Krystyna Dabrowska and Rob Lavigne

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Viruses of Microbes 2024 Immune responses to phages (Front Immunol) Engineering bacteriolytic enzymes (Front Immunol) 100 cases of phage therapy (Nat Micro) Synthetic biology potential of bacteriophages (Nat Micro) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1152: Clinical update with Dr. Daniel Griffin

    TWiV 1152: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin deep dives into the durability of the antibody response following mpox vaccination, vaccine security, global mpox circulation, the origins of SARS-CoV-2, including a list TWiV episodes and combatting scientific misinformation, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if remdesivir + dexamethasone lowers mortality of hospitalized COVID-19 patients and the finding of how SARS-CoV-2 infection impacts memory and cognition.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Waning vaccine protection against mpox
..isn’t this the way the humoral immune response works? (CIDRAP) 1:46 Uncontrollable mpox outbreak in Africa (Reuters) 4:10 Antibodies elicited by the Jynneos vaccine against mpox contract after 6-9 months
.can you believe? (medrxiv) 4:45 Mpox vaccine for adolescents approved (Pharmaceutical Technology) 14:05 Clade 1b mpox visiting India (CIDRAP) 15:05 Mpox clade 1b in Kerala (ANI South Asia’s Leading Multimedia News Agency) 15:13 US government orders $63M worth of small pox/mpox vaccine (Reuters) 15:34 Mpox donations boosting global supply (US Department of Health and Human Services) 1 million mpox vaccine doses for Africa
.with love from US government (CIDRAP) 15:55 Speed doses of mpox vaccine (CIDRAP) Mpox vaccine donations (UNICEF) 17:35 Bavarian Nordic mpox vaccine (Yahoo finances) Early epicenter of COVID-19 pandemic Huanan seafood market (Science) 23:07 Wildlife trade likely source of SARS-CoV-2 (Science) 23:16 Zoonotic origins of SARS-CoV-2 (Science) 23:20 Surveillance at the Huanan Seafood market (Europe PMC) 25:03 TWiV shout outs
..all for the SARS-CoV-2 spill over from nature 25:31 TWiV 1019: Eddie Holmes on SARS-CoV-2 origins TWiV 1017: From Nature, not a lab TWiV 995: Viral origin stories TWiV 940: Eddie Holmes in on viral origins TWiV 876: Spillover market with Michael Worobey TWiV 762: SARS-CoV-2 origins with Robert Garry TWiV 760: SARS-CoV-2 origins with Peter Daszak, Thea Kþlsen Fischer, Marion Koopmans TWiV 774: Kristian Andersen, Robert Garry, and the deleted SARS-CoV-2 sequences Genetic tracing of market wildlife and viruses at Huanan Market (Cell) 18:56 Combatting scientific misinformation (microbeTV: TWiV) 34:14 COVID-19 deaths (CDC) 35:20 COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Suggestion for the use of a new preventive COVID-19 agent (IDSA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir outcomes 3 and 6 months after treatment (LANCET Infectious Diseases) Antivirals and post-COVID-19 conditions (LANCET Infectious Disease) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Lower mortality risk associated with remdesivir + dexamethasone versus dexamethasone for hospitalized COVID-19 patients (CID) 39:17 Changes in memory and cognition during the SARS-CoV-2 human challenge study (eClinical Medicine) 42:25 Letters read on TWiV 1152 48:18 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1151: Hotel California for Phage

    TWiV 1151: Hotel California for Phage

    · This Week in Virology

    TWiV reviews polio vaccination campaign in Gaza, viruses with zoonotic potential in farmed fur animals, low HPV vaccination in North Texas associated with high rates of cervical cancer, a large flavivirus genome that does not encode error correction machinery, and antiphage defense through inhibition of virion assembly.

    Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Jolene Ramsey

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Polio vaccination in Gaza (Reuters) Zoonotic viruses in farmed fur animals (Nature) HPV vaccination and cancer rates (JAMA Net Open) 40 kb RNA genome without error correction (PNAS) Stopping the phage tape measure protein (Nat Commun) Tail assembly interference (Nat Commun) Letters read on TWiV 1151 Timestamps by Jolene. Thanks! Weekly Picks

    Dickson – Digital nature pics winners 2024 Wildlife Photographer of the Year
    Alan – Adorable story about a Nigerian paralympian couple who are both polio survivors
    Jolene – Capsid assembly model with self-assembling pentamers in 3D print model (plus three more models now available if search self assembling virus) and Wonderlab article about exhibit using this to teach about viral patterns in Bloomington Indiana Science museum
    Vincent – The collapse of bat populations led to more than a thousand infant deaths

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1150: Clinical update with Dr. Daniel Griffin

    TWiV 1150: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin dives into West Nile virus in New Jersey, poliovirus vaccination campaign in Gaza and Afghanistan, California dengue virus infections, children dying from flu, mpox vaccination procurement and antiviral usage, flu circulation in US, before reviewing the recent statistics on SARS-CoV-2 infection, finding a new wasterwater dashboard, if the monovalent XBB.1.5 COVID-19 vaccine is effective against circulating SARS-CoV-2 isolates, the need for nasal mucosal IgA in response to SARS-CoV-2 infection, where to find PEMGARDA, does administration of molnupiravir reduce symptoms in the vaccinated, when to use convalescent plasma, how molnupiravir treatment leads to better outcomes 3 and 6 months after treatment, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if vaccination against SARS-CoV-2 does protect against long COVID, and if those taking the anti-diabetic drug metformin have higher or lower incidences of long COVID.

    Subscribe (free): Apple Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode West Nile virus in New Jersey (CBSNews) Poliovirus vaccination 90% coverate (Reuters) Suspension of poliovirus eradication by the Taliban (apnews) California dengue cluster (CIDRAP) Children dying of influenza (CIDRAP) 199 children deaths from flu (CDC) Bavarian Nordic mpox vaccine (Yahoo finances) Prequalification of MVA-BN mpox vaccine (WHO Int) Speed doses of mpox vaccine (CIDRAP) GAVI rapidly secures 500K doses of mpox vaccines for Africa(GAVI) Expanded access to teconvirimat for mpox treatment in US 2022-2023(NEJM Evidence) FluView (CDC) Human to human transmission of bird flu in Missouri? (NY Times) Bird flu isolated from humans in Missouri similar to that found in cattle (CNN) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage (CID) Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution (JID) Suggestion for the use of a new preventive COVID-19 agent (IDSA) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Lierpool) Molnupiravir outcomes 3 and 6 months after treatment (LANCET Infectious Diseases) Antivirals and post-COVID-19 conditions (LANCET Infectious Disease) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Metformin use in adults with diabetes and incidence of long COVID (Diabetes Care) Letters read on TWiV 1150 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1149: Mary Estes, a gutsy virologist

    TWiV 1149: Mary Estes, a gutsy virologist

    · This Week in Virology

    From the annual meeting of the American Society for Virology, Kathy and Brianne speak with Mary Estes about her career and the research of her laboratory on viruses that infect the gastrointestinal tract, including rotavirus and norovirus.

    Hosts: Kathy Spindler and Brianne Barker

    Guest: Mary Estes

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Diarrhea induced by rotavirus NSP4 (Science) Minimal infective dose of rotavirus (Arch Virol) mRNA release from rotavirus particles (Nat Struct Biol) Norovirus vaccine (Clin Ther) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1148: Clinical update with Dr. Daniel Griffin

    TWiV 1148: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin dives into “pandemic potential” viruses isolated from farmed fur animals, how the mRNA and pox vectored vaccines against mpox spar against each other, how telehealth does managing mpox, and if prophylactic use of the anti-RSV monoclonal for infants is cost-effective before reviewing the recent statistics on SARS-CoV-2 infection, if viral load correlates to one vaccination status, where to find PEMGARDA, does administration of molnupiravir reduce symptoms in the vaccinated, when to use convalescent plasma, how molnupiravirs treatment leads to better outcomes 3 and 6 months after treatment, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if vaccination against SARS-CoV-2 does protect against long COVID, and if SARS-CoV-2 during Omicron alters ones’ micriobiota.

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Lending you the viruses in my fur (Nature) mRNA or vaccinia based mpox vaccine (Cell) Virtual outpatient management of mpox (OFID) NYC: mpox vaccination finder (NYC) Vaccine, mpox/COVID-19 near you (NYC) Expensive or not expensive anti-RSV monoclonal therapy for infants (American Academy of Pediatrics) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Association of vaccination and SARS-CoV-2 viral load phase 3 (JID) IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (IDSA) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Early phase of SARs-CoV-2 infection (COVID.gov) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir outcomes 3 and 6 months after treatment (LANCET Infectious Diseases) Antivirals and post-COVID-19 conditions (LANCET Infectious Disease) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Long COVID following infection with Omicron: oral microbiota changes(American Journal of Medicine) Letters read on TWiV 1148 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • TWiV 1147: Breastmilk paradox for norovirus

    TWiV 1147: Breastmilk paradox for norovirus

    · This Week in Virology

    TWiV reviews multi-country outbreak of Mpox, first face covering ban in Nassau County NY, case of polio in India, more in US accept vaccine misinformation, other wartime diseases in Gaza besides polio, a new scientist run virus genome database, Mpox epidemiology and vaccine effectiveness in England, and metabolic immaturity and breastmilk bile acid metabolites determine heightened newborn vulnerability to norovirus diarrhea.

    Hosts: Vincent Racaniello, Rich Condit, and Brianne Barker

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode MicrobeTV Discord Server Multi-country Mpox outbreak (WHO) Face covering ban in Nassau County (NBC) Polio case in India (Business Standard) More acceptance of vaccine misinformation (EurekAlert) War in Gaza not just causing polio (Jerusalem Post) Scientist run virus genome database (Science) Mpox epidemiology and vaccine effectiveness (Emerg Inf Dis) Newborn vulnerability to norovirus diarrhea (Cell Host Microbe) Timestamps by Jolene. Thanks! Weekly Picks

    Brianne – Viral adaptation to climate change
    Rich – “Understanding the biology of monkeypox virus to prevent future outbreaks” by B. Moss
    Vincent – We can now watch Grace Hopper’s famed 1982 lecture on YouTube

    Intro music is by Ronald Jenkees

    Send your virology questions and comments to [email protected]

    Content in this podcast should not be construed as medical advice.

  • TWiV 1146: Clinical update with Dr. Daniel Griffin

    TWiV 1146: Clinical update with Dr. Daniel Griffin

    · This Week in Virology

    In his weekly clinical update, Dr. Griffin discusses seasonal influenza vaccine recommendations from the CDC, polio vaccine campaign securing mpox vaccine for Africa, and donating to reduce food insecurity in mpox affected areas before reviewing the recent statistics on SARS-CoV-2 infection, where to find PEMGARDA, when to use convalescent plasma, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if vaccination against SARS-CoV-2 does protect against long COVID, how fibrin drives thromboinflammation and neuropathology in COVID-19, and an evidence based approach to long COVID.

    Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

    Become a patron of TWiV!

    Links for this episode Recommendations for seasonal influenza prevention and vaccines (MMWR) Gaza: poliovirus RNA in sewage water (Reuters) Success of the polio vaccination campaign in Gaza (Reuters) UNICEF-Gavi-WO-Africa CDC securing mpox vaccines (Gavi) mpox vaccine tender (CIDRAP) What about vaccines? (Bavarian Nordic) Resolving food insecurity (UNICEF USA) Semaglutide and the SELECT trial(Journal of the American College of Cardiology) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) CDC Quarantine guidelines (CDC) Early phase of SARs-CoV-2 infection (COVID.gov) NIH COVID-19 treatment guidelines (NIH) Infectious Disease Society guidelines for treatment and management (ID Society) Drug interaction checker (University of Liverpool) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Optimal duration of systemic corticosteroids treatment (OFID) Steroids,dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Does vaccination prevent long COVID (LANCET: Respiratory Medicine) Fibrin drives thromboinflammation & neuropathology in COVID-19(Nature) Postacute sequelae of COVID: an evidenced based approach, Dr. Daniel Griffin (OFID) Letters read on TWiV 1146 Dr. Griffin’s COVID treatment summary (pdf) Timestamps by Jolene. Thanks!

    Intro music is by Ronald Jenkees

    Send your questions for Dr. Griffin to [email protected]

  • Mostra di più